Phone: Case Studies
Co-Promotion Optimization
AUTHOR: CMK SELECT
A notable pharmaceutical company had agreed to co-promote a drug and, in turn, was obligated to provide a list of contractual deliverables to the partner…CONTINUE READING
CMK Select Supports Pharmaceutical Leader in Delivering Next-gen Data & Digital Strategy by Driving Successful Change Management
AUTHOR: CMK SELECT
The Challenge When the U.S. Oncology team of a global pharmaceutical company were ready to execute on the vision of industry-leading engagement, they looked to…CONTINUE READING
CMK Select Works With Life Sciences Data Analytics Team to Explore Key Project Management Knowledge Areas
AUTHOR: CMK SELECT
The Challenge A Client’s Life Sciences data analytics team was seeking to gain foundational knowledge of project management. The team’s existing work environment centered around…CONTINUE READING
CMK Brings Order to Pharma Company’s Struggling Multi-Product, Multi-Release Launch
AUTHOR: CMK SELECT
The Challenge A privately owned, rapidly growing pharmaceutical company was charged with rolling out 22 releases for a multi-product launch in one year’s time. In…CONTINUE READING
CMK Helps Global Pharmaceutical Leader Streamline Processes and Protocols to Meet Government Requirements and Deliver Ongoing Operational Efficiencies
AUTHOR: CMK SELECT
The Challenge The U.S. cardiovascular team of a global pharmaceutical company needed help responding to a new Corporate Integrity Agreement for two launch products. Resource-constrained…CONTINUE READING
Pharma Giant Sees Six-Fold Boost in Awareness of New Myeloid Disease Treatment With CMK Select
AUTHOR: CMK SELECT
The Challenge Within hematology, Higher Risk-Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia (AML) are diseases with a highly unmet treatment need. In response, an NJ-based…CONTINUE READING
CMK Helps Pharmaceutical Leader Streamline and Integrate Processes and Procedures for Study Teams Following Merger
AUTHOR: CMK SELECT
The Challenge When two large pharmaceutical companies merged, the study teams struggled with a lack of clarity over which operating models to follow for their…CONTINUE READING
Risk Evaluation and Mitigation Strategies (REMS) B2B Services
AUTHOR: CMK SELECT
The Challenge A pharmaceutical technology company originally created a tool to validate the safety of medications, and while the tool effectively met the initial goal,…CONTINUE READING
Clinical Data Standards
AUTHOR: CMK SELECT
Following the December 17, 2014, FDA binding guidance that all pharma studies starting after December 17, 2016, must conform to a set of FDA-sponsored standards,…CONTINUE READING
Medical Events Compliance
AUTHOR: CMK SELECT
A major pharmaceutical company was in need of a review and approval process to help streamline the planning and execution of its external medical events.…CONTINUE READING
Commercial IT Application Rationalization as a Result of Pharma M&A
AUTHOR: CMK SELECT
The Challenge A biotechnology company was preparing for a merger and had no formal M&A processes in place for IT specifically. Most of its existing…CONTINUE READING
